376 related articles for article (PubMed ID: 18812218)
1. Microneedle mediated delivery of nanoparticles into human skin.
Coulman SA; Anstey A; Gateley C; Morrissey A; McLoughlin P; Allender C; Birchall JC
Int J Pharm; 2009 Jan; 366(1-2):190-200. PubMed ID: 18812218
[TBL] [Abstract][Full Text] [Related]
2. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
Xie Y; Xu B; Gao Y
Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
[TBL] [Abstract][Full Text] [Related]
3. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
[TBL] [Abstract][Full Text] [Related]
4. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
[TBL] [Abstract][Full Text] [Related]
5. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
6. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles.
Zhang W; Gao J; Zhu Q; Zhang M; Ding X; Wang X; Hou X; Fan W; Ding B; Wu X; Wang X; Gao S
Int J Pharm; 2010 Dec; 402(1-2):205-12. PubMed ID: 20932886
[TBL] [Abstract][Full Text] [Related]
7. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin.
Chen H; Zhu H; Zheng J; Mou D; Wan J; Zhang J; Shi T; Zhao Y; Xu H; Yang X
J Control Release; 2009 Oct; 139(1):63-72. PubMed ID: 19481577
[TBL] [Abstract][Full Text] [Related]
8. A simple method of microneedle array fabrication for transdermal drug delivery.
Kochhar JS; Goh WJ; Chan SY; Kang L
Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
[TBL] [Abstract][Full Text] [Related]
9. Microfabricated silicon microneedles for nonviral cutaneous gene delivery.
Chabri F; Bouris K; Jones T; Barrow D; Hann A; Allender C; Brain K; Birchall J
Br J Dermatol; 2004 May; 150(5):869-77. PubMed ID: 15149498
[TBL] [Abstract][Full Text] [Related]
10. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
Li G; Badkar A; Nema S; Kolli CS; Banga AK
Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles.
Coulman SA; Barrow D; Anstey A; Gateley C; Morrissey A; Wilke N; Allender C; Brain K; Birchall JC
Curr Drug Deliv; 2006 Jan; 3(1):65-75. PubMed ID: 16472095
[TBL] [Abstract][Full Text] [Related]
12. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
13. Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation.
Cross SE; Innes B; Roberts MS; Tsuzuki T; Robertson TA; McCormick P
Skin Pharmacol Physiol; 2007; 20(3):148-54. PubMed ID: 17230054
[TBL] [Abstract][Full Text] [Related]
14. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
15. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
16. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes.
Dubey V; Mishra D; Asthana A; Jain NK
Biomaterials; 2006 Jun; 27(18):3491-6. PubMed ID: 16513163
[TBL] [Abstract][Full Text] [Related]
17. Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies.
Shakeel F; Ramadan W; Ahmed MA
J Drug Target; 2009 Jul; 17(6):435-41. PubMed ID: 19527114
[TBL] [Abstract][Full Text] [Related]
18. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.
Kohli AK; Alpar HO
Int J Pharm; 2004 May; 275(1-2):13-7. PubMed ID: 15081134
[TBL] [Abstract][Full Text] [Related]
19. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations.
So JW; Park HH; Lee SS; Kim DC; Shin SC; Cho CW
Drug Deliv; 2009 Jan; 16(1):52-6. PubMed ID: 19555309
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation.
Birchall J; Coulman S; Anstey A; Gateley C; Sweetland H; Gershonowitz A; Neville L; Levin G
Int J Pharm; 2006 Apr; 312(1-2):15-23. PubMed ID: 16469457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
